SEC Form 4 · accession 0001144204-15-064825
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Doron
Director
Period of report
Jul 24, 2015
Accepted (ET)
Nov 12, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 24, 2015 | A | 3,353 | — | A | 63,138 | D | |
| Common StockF1 | Oct 23, 2015 | A | 7,010 | — | A | 70,148 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were an award under the Issuer's 2015 Equity Incentive Compensation Plan.